Latest Production News

TruScreen Group Limited forecasts a robust 64% increase in FY26 sales, driven by strategic market expansions and new distribution agreements. The company’s AI-enabled cervical cancer screening technology is gaining traction across emerging markets.

TruScreen Group Limited has announced a NZ$3 million capital raise to fund strategic growth initiatives across Asia and Africa, alongside repaying existing debt. The raise includes a placement and share purchase plan with free attaching options, signaling confidence in its expanding cervical cancer screening programs.

Knosys Limited is reshaping its future by focusing on its Libero library management platform, aiming to become a global leader through strategic simplification, AI innovation, and geographic expansion.

ReadCloud Limited reports a robust first half FY25 with 13% organic revenue growth and a 73% jump in underlying EBITDA, powered by its expanding VET-in-Schools segment and disciplined cost management.

The ACCC has issued a preliminary Statement of Issues regarding Elders Limited’s proposed acquisition of Delta Agribusiness, signaling potential competition challenges that could affect the deal’s timeline.

Ionic Rare Earths has announced a $3 million capital raise via convertible notes, aimed at advancing its rare earth projects across multiple continents. The raise, pending shareholder approval, underscores the company’s strategic push into sustainable rare earth extraction and recycling technologies.

Elsight Limited has expanded its supply agreement with a European defence drone OEM to a total of US$9.63 million for 2025, positioning the company for profitability and cash flow break-even this year.

Uvre has cleared a crucial regulatory hurdle in its acquisition of New Zealand’s Waitekauri Gold Project, setting the stage for new leadership and exploration activities.

Javelin Minerals’ maiden drilling at the Eureka Gold Project reveals significant high-grade gold mineralisation outside the existing resource, setting the stage for near-term mining and resource expansion.

The ACCC has raised preliminary concerns that Elders’ proposed acquisition of Delta Agribusiness could reduce competition in rural merchandise supply across key Australian regions, potentially impacting prices and service quality.

Clarity Pharmaceuticals has successfully imaged the first patient in its pivotal Phase III AMPLIFY trial for Cu-SAR-bisPSMA, a next-generation diagnostic agent targeting recurrent prostate cancer. This milestone sets the stage for potential FDA approval and broader clinical adoption.

BP8 has completed its inaugural shipment of Indonesian seaweed biomass to South Korean manufacturer MSC, Ltd., under a new sales cooperation agreement with PT Kebula Raya Bestari. This initial contract signals BP8’s growing footprint in the global seaweed supply chain.